surf break copy_edited.jpg

Series A Metrics

By: Annelies Gamble

This doc is meant to provide some high level insights and direction to Seed companies as they begin preparing for their Series A. Metrics for Series A rounds are much less clear than they used to be and different investors have different frameworks for evaluating Series A opportunities. That said, there are signals that every Series A investor is looking for. Knowing these signals can help you know when to begin fundraising and how best to prepare for investor conversations.


Recent Posts

See All

Emerging Opportunities: Real-World Evidence

Key takeaways • Real-world evidence (RWE) has the potential to be useful across the entire healthcare ecosystem, including for clinical trials, care provision, determining treatment outcomes, and post

Invitae to Acquire Ciitizens

Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z